Preparing for avian influenza

Current Opinion in Pediatrics

Volumn 19, Issue 1, 2007, Pages 64-70

  Martinello, Richard A ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Mail Code 11 ACSL G ^*  (United States)

Author keywords

Disease outbreaks; Healthcare facilities; Humans; Infection control; Influenza; Influenza in birds

Indexed keywords

ANTIVIRUS AGENT; AVIAN INFLUENZA VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR;

AVIAN INFLUENZA; DISEASE TRANSMISSION; EMERGENCY HEALTH SERVICE; HEALTH CARE FACILITIES AND SERVICES; HUMAN; INFECTION CONTROL; INTERPERSONAL COMMUNICATION; LABORATORY TEST; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; RESOURCE MANAGEMENT; REVIEW; SOCIAL ASPECT; TREATMENT PLANNING; VACCINATION;

ANIMALS; BIRDS; DISASTER PLANNING; DISEASE OUTBREAKS; HEALTH FACILITIES; HEALTH PLANNING GUIDELINES; HUMANS; INFECTION CONTROL; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; UNITED STATES;

EID: 33846280164     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328013cd13     Document Type: Review

References (77)

1. Webster RG, Hay AJ. The H5N1 influenza outbreak in Hong Kong: A test of pandemic preparedness. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Malden: Blackwell Science; 1998. pp. 561-565.
2. de Jong JC, Claas EC, Osterhaus AD, et al. A pandemic warning? Nature 1997; 389:554.
3. Claas EC, Osterhaus AD, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351:472-477.
4. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351:467-471.
5. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1); 23 August 2006. http://www.who.int/csr/disease/ avian_influenza/country/cases_table_2006_08_23/en/index.html. [Accessed 5 September 2006]
6. Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 'Spanish' influenza pandemic. Bull Hist Med 2002; 76:105-115.
7. Potter CW. Chronicle of influenza pandemics. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Malden: Blackwell Science; 1998. pp. 3-18.
8. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006; 12:9-14.
9. Reid AH, Taubenberger JK, Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes Infect 2001; 3:81-87.
10. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005; 352:1839-1842.
11. Arnold R, De Sa J, Gronniger T, et al. A potential influenza pandemic: possible macroeconomic effects and policy issues. Washington, DC: Congressional Budget Office; 2005.
12. US Department of Health and Human Services. HHS pandemic influenza plan; November 2005. http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan. pdf. [Accessed 5 September 2006]
13. Rubinson L, Branson RD, Pesik N, Talmor D. Positive-pressure ventilation equipment for mass casualty respiratory failure. Biosecur Bioterror 2006; 4:183-194.
14. Loutfy MR, Wallington T, Rutledge T, et al. Hospital preparedness and SARS. Emerg Infect Dis 2004; 10:771-776.
15. World Health Organization. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Weekly Epidemiological Record 2006; 81:249-260.
16. Centers for Disease Control and Prevention. FluSurge; 7 June 2006. http://www.cdc.gov/flu/flusurge.htm. [Accessed 5 September 2006] This provides spreadsheet software that calculates an estimate of the number of patients requiring hospitalization, intensive care, mechanical ventilation and death.
17. US Department of Health and Human Services. Pandemic flu planning checklist for individuals and families; May 2006. http://www.pandemicflu.-gov/ planguide/checklist.html. [Accessed 5 September 2006] This is a useful website with content for developing personal and family emergency plans.
18. Red Cross, Centers for Disease Control and Prevention. Preparedness today; 2006. http://www.redcross.org/preparedness/cdc_english/home.asp. [Accessed 5 September 2006] This is a useful website with content for developing personal and family emergency plans.
19. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in healthcare settings. Clin Infect Dis 2003; 37:1094-1101.
20. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002; 2:145-155.
21. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006; 12:1657-1662.
22. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353:1374-1385. This is an outstanding review of H5N1 influenza.
23. Schultsz C, Dong VC, Chau NV, et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis 2005; 11:1158-1159.
24. Olsen SJ, Ungchusak K, Sovann L, et al. Family clustering of avian influenza A (H5N1). Emerg Infect Dis 2005; 11:1799-1801.
25. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352:333-340.
26. Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai healthcare workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis 2005; 40:e16-e18.
27. Liem NT, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005; 11:210-215.
28. Centers for Disease Control and Prevention. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza; 21 May 2004. http://www.cdc.gov/flu/avian/ professional/pdf/infectcontrol.pdf. [Accessed 5 September 2006]
29. World Health Organization. Avian influenza, including influenza A (H5N1), in humans: WHO interim infection control guideline for healthcare facilities; 24 April 2006. http://www.who.int/csr/disease/avian_influenza/guidelines/ infectioncontrol1/en/index.html. [Accessed 5 September 2006]
30. Department of Health and Human Services. HHS pandemic influenza plan; 30 March 2006. http://www.hhs.gov/pandemicflu/plan/. [Accessed 5 September 2006]
31. Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437:209-214.
32. Germann TC, Kadau K, Longini IM Jr, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A 2006; 103:5935-5940.
33. World Health Organization. WHO pandemic influenza draft protocol for rapid response and containment; 17 March 2006. http://www.who.int/csr/disease/ avian_influenza/guidelines/pandemicfluprotocol_17.03a.pdf. [Accessed 5 September 2006]
34. Bell DM. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis 2006; 12:88-94.
35. Glass RJ, Glass LM, Beyeler WE, Min HJ. Targeted social distancing design for pandemic influenza. Emerg Infect Dis 2006; 12:1671-1681.
36. Centers for Disease Control and Prevention. Community containment measures, including non-hospital isolation and quarantine; 8 January 2004. http://www.cdc.gov/ncidod/sars/guidance/D/word/rationale.doc. [Accessed 5 September 2006]
37. Dwosh HA, Hong HH, Austgarden D, et al. Identification and containment of an outbreak of SARS in a community hospital. Can Med Assoc J 2003; 168:1415-1420.
38. Svoboda T, Henry B, Shulman L, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med 2004; 350:2352-2361.
39. Centers for Disease Control and Prevention. Respiratory hygiene/cough etiquette in healthcare settings. http://www.cdc.gov/flu/professionals/pdf/ resphygiene.pdf. [Accessed 5 September 2006]
40. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344:889-896.
41. Glezen WP. Influenza control. N Engl J Med 2006; 355:79-81.
42. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:31-40.
43. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352:686-691.
44. Centers for Disease Control and Prevention. Crisis & emergency risk communication: by leaders for leaders. http://www.cdc.gov/communication/ emergency/leaders.pdf#search= %22%22crisis%20and%20emergency%20risk%20communication%22%22. [Accessed 5 September 2006] This excellent text provides an overview of how to provide effective communications during a public crisis.
45. Department of Health and Human Services. Pandemic influenza preevent message maps; 2006. http://www.pandemicflu.gov/rcommunication/pre_event_maps. pdf#search=%22%22pandemic%20influenza%20pre-event%20message%20maps%22%22. [Accessed 5 September 2006]
46. Cooper NJ, Sutton AJ, Abrams KR, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. Br Med J 2003; 326:1235.
47. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353:1363-1373. This is a review of the clinical aspects of the neuraminidase inhibitors.
48. Aoki FY. Amantidine and rimantidine. In: Nicholson KG, Webster RG, Hay AJ, editors. Textbook of influenza. Malden: Blackwell Science; 1998. pp. 457-476.
49. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001; 20:127-133.
50. Townsend KA, Eiland LS. Combating influenza with antiviral therapy in the pediatric population. Pharmacotherapy 2006; 26:95-103.
51. Aoki FY, Macleod MD, Paggiaro P, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003; 51:123-129.
52. Ward P, Small I, Smith J, et al. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 2005; 55 (Suppl 1):i5-i21.
53. Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350:1179-1188.
54. Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363:587-593.
55. Yen HL, Monto AS, Webster RG, Govorkova EA. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 2005; 192:665-672.
56. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617-619.
57. Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005; 437:1108.
58. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353:2667-2672.
59. Longini IM Jr, Halloran ME, Nizam A, Yang Y. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004; 159:623-633.
60. Lee VJ, Phua KH, Chenm MI, et al. Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore. Emerg Infect Dis 2006; 12:95-102.
61. Hayden FG. Pandemic influenza: is an antiviral response realistic? Pediatr Infect Dis J 2004; 23:S262-S269.
62. Longini IM Jr, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science 2005; 309:1083-1087.
63. Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006; 354:1343-1351.
64. Luke CJ, Subbarao K. Vaccines for pandemic influenza. Emerg Infect Dis 2006; 12:66-72.
65. Poland GA. Vaccines against avian influenza-a race against time. N Engl J Med 2006; 354:1411-1413.
66. Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004; 431:703-707.
67. Longini IM Jr, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 2005; 161:303-306.
68. Smith NM, Bresee JS, Shay DK, et al. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-42.
69. Halloran ME, Longini IM Jr. Public health Community studies for vaccinating schoolchildren against influenza. Science 2006; 311:615-616.
70. Reichert TA. The Japanese program of vaccination of schoolchildren against influenza: implications for control of the disease. Semin Pediatr Infect Dis 2002; 13:104-111.
71. Sugaya N, Takeuchi Y. Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan. Clin Infect Dis 2005; 41:939-947.
72. Piedra PA, Gaglani MJ, Kozinetz CA, et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 2005; 23:1540-1548.
73. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-16.
74. Talbot TR, Bradley SE, Cosgrove SE, et al. Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol 2005; 26:882-890.
75. Cosgrove SE, Fishman NO, Talbot TR, et al. Strategies for use of a limited influenza vaccine supply. JAMA 2005; 293:229-232.
76. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355:93-97.
77. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of healthcare workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175:1-6.